1. Home
  2. INDP

as of 12-01-2025 3:59pm EST

$1.95
$0.22
-10.34%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Chart Type:
Time Range:
Founded: 2000 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 4.0M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 40.8K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -27.45 EPS Growth: N/A
52 Week Low/High: $1.65 - $47.60 Next Earning Date: 11-12-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered INDP Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 66.67%
66.67%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: